MedPath

Calcitonin Salmon

These highlights do not include all the information needed to use CALCITONIN SALMON INJECTION safely and effectively. See full prescribing information for CALCITONIN SALMON INJECTION. CALCITONIN SALMON injection, synthetic, for subcutaneous or intramuscular use Initial U.S. Approval: 1975

Approved
Approval ID

ece693d8-1832-4b85-8736-819163ba56c1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 1, 2017

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcitonin Salmon

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42023-205
Application NumberANDA209358
Product Classification
M
Marketing Category
C73584
G
Generic Name
Calcitonin Salmon
Product Specifications
Route of AdministrationINTRAMUSCULAR, SUBCUTANEOUS
Effective DateNovember 22, 2021
FDA Product Classification

INGREDIENTS (6)

CALCITONIN SALMONActive
Quantity: 200 [iU] in 1 mL
Code: 7SFC6U2VI5
Classification: ACTIB
ACETIC ACIDInactive
Quantity: 2.25 mg in 1 mL
Code: Q40Q9N063P
Classification: IACT
SODIUM ACETATEInactive
Quantity: 2 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 7.5 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
PHENOLInactive
Quantity: 5 mg in 1 mL
Code: 339NCG44TV
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Calcitonin Salmon - FDA Drug Approval Details